Endocrinology

Back to articles

Osteoporosis Treatment Strategies Reviewed by NIH Panel

KEY POINT

Lack of improvement in bone-mineral density (BMD) does not justify stopping prevention or treatment strategies in patients with osteoporosis. This was the conclusion of a consensus development panel recently convened at NIH. Clinicians should remember that the primary goal of osteoporotic therapies is prevention of bone fractures, and BMD, while perhaps a useful measure for assessing care, is not a primary clinical outcome.

SOURCES

NIH Consensus Development Conference. Osteoporosis prevention, diagnosis, and therapy. JAMA. 2001;285:785–95.